Does RUXOLITINIB Cause Cholelithiasis? 107 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 107 reports of Cholelithiasis have been filed in association with RUXOLITINIB (OPZELURA). This represents 0.2% of all adverse event reports for RUXOLITINIB.
107
Reports of Cholelithiasis with RUXOLITINIB
0.2%
of all RUXOLITINIB reports
21
Deaths
72
Hospitalizations
How Dangerous Is Cholelithiasis From RUXOLITINIB?
Of the 107 reports, 21 (19.6%) resulted in death, 72 (67.3%) required hospitalization, and 4 (3.7%) were considered life-threatening.
Is Cholelithiasis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RUXOLITINIB. However, 107 reports have been filed with the FAERS database.
What Other Side Effects Does RUXOLITINIB Cause?
Off label use (12,492)
Death (6,561)
Fatigue (5,663)
Anaemia (3,593)
Haemoglobin decreased (3,297)
Platelet count decreased (3,028)
Diarrhoea (2,531)
Asthenia (2,529)
Dizziness (2,398)
Pneumonia (2,343)
What Other Drugs Cause Cholelithiasis?
ADALIMUMAB (1,238)
OCTREOTIDE (641)
SEMAGLUTIDE (571)
METHOTREXATE (466)
TIRZEPATIDE (386)
PREDNISONE (346)
ETANERCEPT (345)
ACETAMINOPHEN (313)
LENALIDOMIDE (308)
CEFTRIAXONE (306)
Which RUXOLITINIB Alternatives Have Lower Cholelithiasis Risk?
RUXOLITINIB vs SABRIL
RUXOLITINIB vs SACCHAROMYCES CEREVISIAE
RUXOLITINIB vs SACITUZUMAB GOVITECAN
RUXOLITINIB vs SACITUZUMAB GOVITECAN-HZIY
RUXOLITINIB vs SACROSIDASE